BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29073495)

  • 1. What's up in the ALPS.
    Rieux-Laucat F
    Curr Opin Immunol; 2017 Dec; 49():79-86. PubMed ID: 29073495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.
    Rieux-Laucat F; Magérus-Chatinet A; Neven B
    J Clin Immunol; 2018 Jul; 38(5):558-568. PubMed ID: 29911256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next Generation Sequencing for Detecting Somatic
    López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
    Front Immunol; 2021; 12():656356. PubMed ID: 33995372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
    Consonni F; Gambineri E; Favre C
    Ann Hematol; 2022 Mar; 101(3):469-484. PubMed ID: 35059842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expanding spectrum of the autoimmune lymphoproliferative syndromes.
    Oliveira JB
    Curr Opin Pediatr; 2013 Dec; 25(6):722-9. PubMed ID: 24240292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome.
    Pellé O; Moreno S; Lorenz MR; Riller Q; Fuehrer M; Stolzenberg MC; Maccari ME; Lenoir C; Cheminant M; Hinze T; Hebart HF; König C; Schvartz A; Schmitt Y; Vinit A; Henry E; Touzart A; Villarese P; Isnard P; Neveux N; Landman-Parker J; Picard C; Fouyssac F; Neven B; Grimbacher B; Speckmann C; Fischer A; Latour S; Schwarz K; Ehl S; Rieux-Laucat F; Rensing-Ehl A; Magérus A
    J Allergy Clin Immunol; 2024 Jan; 153(1):203-215. PubMed ID: 37793571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in autoimmune lymphoproliferative syndromes.
    Madkaikar M; Mhatre S; Gupta M; Ghosh K
    Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid ex vivo clinical diagnostic assay for fas receptor-induced T lymphocyte apoptosis.
    Lo B; Ramaswamy M; Davis J; Price S; Rao VK; Siegel RM; Lenardo MJ
    J Clin Immunol; 2013 Feb; 33(2):479-88. PubMed ID: 23054345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome.
    Janda A; Schwarz K; van der Burg M; Vach W; Ijspeert H; Lorenz MR; Elgizouli M; Pieper K; Fisch P; Hagel J; Lorenzetti R; Seidl M; Roesler J; Hauck F; Traggiai E; Speckmann C; Rensing-Ehl A; Ehl S; Eibel H; Rizzi M
    Blood; 2016 May; 127(18):2193-202. PubMed ID: 26907631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).
    Lisco A; Wong CS; Price S; Ye P; Niemela J; Anderson M; Richards E; Manion M; Mystakelis H; Similuk M; Lo B; Stoddard J; Rosenzweig S; Vanpouille C; Rupert A; Maric I; Perez-Diez A; Parenti D; Burbelo PD; Rao VK; Sereti I
    Front Immunol; 2019; 10():1193. PubMed ID: 31191551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS).
    Casamayor-Polo L; López-Nevado M; Paz-Artal E; Anel A; Rieux-Laucat F; Allende LM
    Crit Rev Clin Lab Sci; 2021 Jun; 58(4):253-274. PubMed ID: 33356695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pearls and pitfalls: Autoimmune lymphoproliferative syndrome and autoimmune lymphoproliferative syndrome-like disease.
    Bartels AK; Banks TA; Bay JL
    Allergy Asthma Proc; 2017 Jul; 38(4):317-321. PubMed ID: 28668112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review.
    Hafezi N; Zaki-Dizaji M; Nirouei M; Asadi G; Sharifinejad N; Jamee M; Erfan Rasouli S; Hamedifar H; Sabzevari A; Chavoshzadeh Z; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
    Pediatr Allergy Immunol; 2021 Oct; 32(7):1519-1532. PubMed ID: 33963613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders.
    Failing C; Blase JR; Walkovich K
    Rheum Dis Clin North Am; 2023 Nov; 49(4):841-860. PubMed ID: 37821199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune pancreatitis in the autoimmune lymphoproliferative syndrome (ALPS): a sheep in wolves' clothing?
    Langan RC; Gill F; Raiji MT; Mullinax JE; Pittaluga S; Pandalai P; Davis J; Perkins K; Avital I; Rudloff U
    Pancreas; 2013 Mar; 42(2):363-6. PubMed ID: 23407489
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
    Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
    Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic landscape of the FAS pathway deficiencies.
    Magerus A; Bercher-Brayer C; Rieux-Laucat F
    Biomed J; 2021 Aug; 44(4):388-399. PubMed ID: 34171534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma.
    Kaya Z; Işık M; Oruklu N; Kirkiz S; Bağrıaçık EÜ; Allende LM; Díaz-Madroñero MJ; Ruiz-García R; Pınarlı FG; Göçün Uyar P; Koçak Ü
    Turk J Haematol; 2021 Jun; 38(2):145-150. PubMed ID: 33375216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes.
    Gámez-Díaz L; Grimbacher B
    Biomed J; 2021 Aug; 44(4):400-411. PubMed ID: 34384744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The autoimmune lymphoproliferative syndrome: A rare disorder providing clues about normal tolerance.
    Turbyville JC; Rao VK
    Autoimmun Rev; 2010 May; 9(7):488-93. PubMed ID: 20170754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.